Vitamin D and subclinical cerebrovascular disease: The atherosclerosis risk in communities brain magnetic resonance imaging study

JAMA Neurology

Volumn 71, Issue 7, 2014, Pages 863-871

  Michos, Erin D ^a,b   Carson, Kathryn A ^a,b   Schneider, Andrea L C ^b   Lutsey, Pamela L ^c   Xing, Li ^d   Sharrett, A Richey ^b   Alonso, Alvaro ^c   Coker, Laura H ^e   Gross, Myron ^c,f   Post, Wendy ^a,b   Mosley, Thomas H ^g   Gottesman, Rebecca F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ATHEROSCLEROSIS; BRAIN INFARCTION; CEREBROVASCULAR DISORDERS; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MISSISSIPPI; NORTH CAROLINA; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; RISK; SEVERITY OF ILLNESS INDEX; VITAMIN D;

EID: 84905457972     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.755     Document Type: Article

References (23)

1. Manolio TA, Kronmal RA, Burke GL, et al Cardiovascular Health Study Collaborative Research Group. Magnetic resonance abnormalities and cardiovascular disease in older adults: the Cardiovascular Health Study. Stroke. 1994;25(2):318-327. (Pubitemid 24047252)
2. Breteler MM, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology. 1994;44(7):1246-1252. (Pubitemid 24232223)
3. Silbert LC, Howieson DB, Dodge H, Kaye JA. Cognitive impairment risk: white matter hyperintensity progression matters. Neurology. 2009;73(2):120-125.
4. Mosley TH Jr, Knopman DS, Catellier DJ, et al. Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study. Neurology. 2005;64(12):2056-2062. (Pubitemid 40880992)
5. Windham BG, Griswold ME, Shibata D, Penman A, Catellier DJ, Mosley TH Jr. Covert neurological symptoms associated with silent infarcts from midlife to older age: the Atherosclerosis Risk in Communities study. Stroke. 2012;43(5):1218-1223.
6. Gottesman RF, Coresh J, Catellier DJ, et al. Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2010;41(1):3-8.
7. 3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110(2):229-238.
8. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49(5):1063-1069. (Pubitemid 351664326)
9. Michos ED, Melamed ML. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care. 2008;11(1):7-12. (Pubitemid 350295219)
10. Wang L, Song Y, Manson JE, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: ameta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012;5(6):819-829.
11. Annweiler C, Allali G, Allain P, et al. Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol. 2009;16(10):1083-1089.
12. Buell JS, Dawson-Hughes B. Vitamin D and neurocognitive dysfunction: preventing "D"ecline? Mol Aspects Med. 2008;29(6):415-422.
13. Brøndum-Jacobsen P, Nordestgaard BG, Schnohr P, Benn M. 25-Hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis. Ann Neurol. 2013;73(1):38-47.
14. Michos ED, Gottesman RF. Vitamin D for the prevention of stroke incidence and disability: promising but too early for prime time. Eur J Neurol. 2013;20(1):3-4.
15. Buell JS, Dawson-Hughes B, Scott TM, et al. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology. 2010;74(1):18-26.
16. Pilz S, Dobnig H, Tomaschitz A, et al. Low 25-hydroxyvitamin D is associated with increased mortality in female nursing home residents. J Clin Endocrinol Metab. 2012;97(4):653-657. doi:10.1210/jc.2011-3043.
17. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129(4):687-702.
18. Hollis BW. Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. Am J Clin Nutr. 2008;88(2):507S-510S.
19. Longstreth WT Jr, Dulberg C, Manolio TA, et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke. 2002;33(10):2376-2382.
20. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36(5):936-942. (Pubitemid 13214364)
21. Pugliese G, Solini A, Bonora E, et al. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) study formula in subjects with type 2 diabetes. Atherosclerosis. 2011;218(1):194-199.
22. Annweiler C, Montero-Odasso M, Muir SW, Beauchet O; WALK Team. Vitamin D and brain imaging in the elderly: should we expect some lesions specifically related to hypovitaminosis D? Open Neuroimag J. 2012;6:16-18.
23. Shoben AB, Kestenbaum B, Levin G, et al. Seasonal variation in 25-hydroxyvitamin D concentrations in the Cardiovascular Health Study. Am J Epidemiol. 2011;174(12):1363-1372.